Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03674983Not ApplicableCompleted

PrEP Seguro: Antiretroviral-based HIV Prevention Among Men at High Risk in Mexico

Role: collaborator

NCT03388398Completed

Evaluation of the Population-level Impact of PMTCT Option B+ in Zimbabwe

Role: collaborator

NCT00737724Not ApplicableTerminated

Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment

Role: collaborator

All 3 trials loaded